Patents by Inventor Bhavya Teja KOLLA

Bhavya Teja KOLLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20240156787
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: January 24, 2024
    Publication date: May 16, 2024
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • Losartan liquid formulations and methods of use
    Patent number: 11890273
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Grant
    Filed: November 2, 2022
    Date of Patent: February 6, 2024
    Assignee: SCIENTURE, INC.
    Inventors: Bhavya Teja Kolla, Rahul Surana, Suketu Sanghvi, Jigar Bhatt
  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20230414574
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: December 5, 2022
    Publication date: December 28, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20230218582
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: November 2, 2022
    Publication date: July 13, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
    Publication number: 20230043204
    Abstract: The present disclosure is directed to formulations and methods for treating or preventing head pain, including migraines, with dihydroergotamine mesylate.
    Type: Application
    Filed: December 21, 2020
    Publication date: February 9, 2023
    Inventors: Shankar HARIHARAN, Bhavya Teja KOLLA, Suketu SANGHVI, Rahul SURANA